ALGS
Aligos Therapeutics Inc

1,210
Loading...
Loading...
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 5, 2018 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
70

Frequently Asked Questions

What is Market Cap of Aligos Therapeutics Inc?
What is the 52-week high for Aligos Therapeutics Inc?
What is the 52-week low for Aligos Therapeutics Inc?
What is Aligos Therapeutics Inc stock price today?
What was Aligos Therapeutics Inc stock price yesterday?
What is the PE ratio of Aligos Therapeutics Inc?
What is the Price-to-Book ratio of Aligos Therapeutics Inc?
What is the 50-day moving average of Aligos Therapeutics Inc?
How many employess does Aligos Therapeutics Inc has?

Latest ALGS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.